GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:GS71 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Feb 24	Buy€64,388	Jonathan Symonds	Individual	3,500	€18.40
01 Feb 24	Buy€358,921	Julie Brown	Individual	19,360	€18.54
20 Dec 23	Buy€33,397	Jonathan Symonds	Individual	2,000	€16.70
20 Dec 23	Buy€8,005	Urs Rohner	Individual	478	€16.75
20 Sep 23	Buy€33,524	Jonathan Symonds	Individual	1,900	€17.64
20 Sep 23	Buy€8,008	Urs Rohner	Individual	453	€17.68
23 Jun 23	Buy€100,882	Jonathan Symonds	Individual	6,000	€16.81
21 Jun 23	Buy€8,045	Urs Rohner	Individual	506	€15.90

Insider Trading Volume

Insider Buying: GS71 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GS71?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,876,139	0.0704%
Individual Insiders	4,580,779	0.112%
State or Government	8,424,577	0.206%
Private Companies	48,858,117	1.2%
Employee Share Scheme	82,340,591	2.02%
General Public	529,680,804	13%
Institutions	3,409,301,742	83.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.23%	Dodge & Cox	377,080,692	€7.3b	-0.58%	3.49%
8.17%	BlackRock, Inc.	333,814,330	€6.4b	-0.21%	0.12%
4.64%	The Vanguard Group, Inc.	189,450,566	€3.7b	2.2%	0.07%
2.35%	State Street Global Advisors, Inc.	96,070,919	€1.9b	1.91%	0.08%
2.21%	Norges Bank Investment Management	90,371,357	€1.7b	-4.83%	0.16%
2.08%	Legal & General Investment Management Limited	84,809,119	€1.6b	2.39%	0.36%
2.02%	GlaxoSmithKline Employee Trust	82,340,591	€1.6b	31.4%	no data
1.64%	Schroder Investment Management Limited	67,162,712	€1.3b	0.29%	0.91%
1.53%	UBS Asset Management AG	62,322,156	€1.2b	4.39%	0.18%
1.36%	Silchester International Investors LLP	55,504,791	€1.1b	0.15%	4.46%
1.32%	FMR LLC	53,986,854	€1.0b	10.4%	0.07%
1.2%	Mondrian Investment Partners Limited	49,224,258	€950.6m	0.16%	6.5%
1.19%	HSBC Global Asset Management (UK) Limited	48,492,384	€936.5m	11%	0.52%
1.18%	GlaxoSmithKline plc, Shareview Client	48,094,521	€928.8m	-0.9%	no data
1.11%	Columbia Management Investment Advisers, LLC	45,417,911	€877.1m	5.21%	0.23%
1.04%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	42,407,746	€819.0m	71%	23.04%
0.9%	Aviva Investors Global Services Ltd.	36,968,007	€713.9m	1.13%	1.1%
0.83%	Wellington Management Group LLP	33,808,189	€652.9m	-2.87%	0.11%
0.82%	Fisher Asset Management, LLC	33,317,889	€643.4m	1.06%	0.33%
0.8%	Franklin Resources, Inc.	32,752,139	€632.5m	4.69%	0.25%
0.75%	JP Morgan Asset Management	30,695,488	€592.8m	3.51%	0.08%
0.74%	Causeway Capital Management LLC	30,220,101	€583.6m	9.95%	2.71%
0.66%	Jupiter Fund Management Plc	26,807,896	€517.7m	-1.48%	1.43%
0.65%	Amundi Asset Management SAS	26,651,354	€514.7m	30.4%	0.11%
0.64%	T. Rowe Price Group, Inc.	26,192,730	€505.8m	1.11%	0.05%